title: What caused excess strokes in patients randomized to darbepoetin in the trial to reduce cardiovascular events with Aranesp therapy (TREAT)?: no smoking gun.
authors.forename: Wolfgang C
authors.initials: WC
authors.lastname: Winkelmayer
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000453:epidemiology*; D000068256:Darbepoetin alfa; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology*; D004921:Erythropoietin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008297:Male; D051436:Renal Insufficiency, Chronic / Q000453:epidemiology*; D020521:Stroke / Q000453:epidemiology* / Q000517:prevention & control*
chemical_list: D004921:Erythropoietin; D000068256:Darbepoetin alfa